WO2004024187A3 - Compositions to reduce congestion and methods for application thereof to the nasal membrane - Google Patents
Compositions to reduce congestion and methods for application thereof to the nasal membrane Download PDFInfo
- Publication number
- WO2004024187A3 WO2004024187A3 PCT/US2003/029329 US0329329W WO2004024187A3 WO 2004024187 A3 WO2004024187 A3 WO 2004024187A3 US 0329329 W US0329329 W US 0329329W WO 2004024187 A3 WO2004024187 A3 WO 2004024187A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nasal membrane
- compositions
- methods
- application
- reduce congestion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003272517A AU2003272517A1 (en) | 2002-09-13 | 2003-09-15 | Compositions to reduce congestion and methods for application thereof to the nasal membrane |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41064102P | 2002-09-13 | 2002-09-13 | |
US60/410,641 | 2002-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004024187A2 WO2004024187A2 (en) | 2004-03-25 |
WO2004024187A3 true WO2004024187A3 (en) | 2004-05-27 |
Family
ID=31994171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/029329 WO2004024187A2 (en) | 2002-09-13 | 2003-09-15 | Compositions to reduce congestion and methods for application thereof to the nasal membrane |
Country Status (3)
Country | Link |
---|---|
US (1) | US7714011B2 (en) |
AU (1) | AU2003272517A1 (en) |
WO (1) | WO2004024187A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT501041B8 (en) * | 2005-02-21 | 2007-02-15 | Elmar Karg | THERAPEUTIC SYSTEM FOR THE TRANSMUCOSOLIC APPLICATION OF A VASO CONSTRUCTOR THROUGH THE NOSES |
US20070110788A1 (en) * | 2005-11-14 | 2007-05-17 | Hissong James B | Injectable formulation capable of forming a drug-releasing device |
WO2007127333A2 (en) * | 2006-04-26 | 2007-11-08 | Aciex, Inc. | Compositions for the treatment and prevention of eyelid swelling |
US20070264296A1 (en) | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
US7959943B2 (en) * | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US7976873B2 (en) * | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
KR100767976B1 (en) | 2006-08-25 | 2007-10-18 | 한국유나이티드제약 주식회사 | Effective pharmaceutical composition for dry nose syndrome |
US8088095B2 (en) * | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
DE102007052380A1 (en) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolyte-containing preparations for use in dry mucous membranes |
EP2303254B1 (en) | 2008-06-12 | 2019-10-30 | Medtronic Xomed, Inc. | Product for treating chronic wounds with an extracellular polymeric substance solvating system |
DE102008039231A1 (en) | 2008-08-22 | 2010-02-25 | Bitop Ag | Use of glucosylglycerol |
US20100086576A1 (en) * | 2008-10-06 | 2010-04-08 | Myntti Matthew F | Antimicrobial composition and methods of making and using same |
EP2706845B1 (en) | 2011-05-10 | 2021-06-23 | Next Science IP Holdings Pty Ltd | Antimicrobial solid and methods of making and using same |
KR20200124556A (en) | 2019-04-24 | 2020-11-03 | 삼성전자주식회사 | Methods of manufacturing pellicle assembly and photomask assembly |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2115848A (en) * | 1934-12-29 | 1938-05-03 | Stanco Inc | Ephedrine composition |
US4724231A (en) * | 1985-04-16 | 1988-02-09 | Nastech Pharmaceutical, Inc. | Nasel compositions containing vitamin B12 |
EP0275054A1 (en) * | 1987-01-14 | 1988-07-20 | Toko Yakuhin Kogyo Kabushiki Kaisha | Ointment base and ointment |
EP0391342A1 (en) * | 1989-04-05 | 1990-10-10 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
WO1994000108A1 (en) * | 1992-06-19 | 1994-01-06 | The Procter & Gamble Company | Topical aromatic releasing compositions |
WO1994005330A1 (en) * | 1992-09-05 | 1994-03-17 | The Procter & Gamble Company | Nasal spray products |
US5760085A (en) * | 1993-04-30 | 1998-06-02 | The Procter & Gamble Company | Topical aromatic releasing compositions |
WO1999038492A1 (en) * | 1998-01-30 | 1999-08-05 | Novartis Consumer Health S.A. | Nasal solutions |
WO2000010530A1 (en) * | 1998-08-24 | 2000-03-02 | The Procter & Gamble Company | Oral liquid mucoadhesive compositions |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
WO2000078297A2 (en) * | 1999-06-22 | 2000-12-28 | Boehringer Ingelheim International Gmbh | Stable xylometazoline and oxymetazoline solution |
US6316483B1 (en) * | 1994-02-03 | 2001-11-13 | Schering Corporation | Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3381733D1 (en) | 1983-12-08 | 1990-08-16 | Toko Yakuhin Kogyo Kk | GEL PREPARATIONS FOR EXTERNAL APPLICATION. |
US4708873A (en) * | 1986-01-29 | 1987-11-24 | Schulte Thomas L | Method of chemically debriding uncerated necrotic tissue |
US4826683A (en) * | 1987-01-09 | 1989-05-02 | Bates Harry L | Decongestant |
US4883660A (en) | 1988-10-17 | 1989-11-28 | Thames Pharmacal Co., Inc. | Gel bases for pharmaceutical compositions |
US5248501A (en) | 1988-11-22 | 1993-09-28 | Parnell Pharmaceuticals | Drug delivery systems containing eriodictyon fluid extract as an excipient, and methods and compositions associated therewith |
US5215739A (en) | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US4970240A (en) | 1989-10-18 | 1990-11-13 | Schering Corporation | Fruity flavored nasal decongestant composition |
US5114979A (en) | 1989-10-18 | 1992-05-19 | Schering Corporation | Fruity flavored nasal decongestant composition |
US5271943A (en) | 1989-10-27 | 1993-12-21 | Scott Health Care | Wound gel compositions containing sodium chloride and method of using them |
US5478565A (en) | 1990-03-27 | 1995-12-26 | Warner-Lambert Company | Treatment of sinus headache |
US5346703A (en) | 1990-08-07 | 1994-09-13 | Mediventures, Inc. | Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels |
SE466134B (en) | 1990-11-22 | 1992-01-07 | Kabi Pharmacia Ab | GEL-PHARMACEUTICAL LIQUID COMPOSITION AND APPLICATION THEREOF IN PHARMACEUTICAL COMPOSITIONS |
US5240694A (en) | 1991-09-23 | 1993-08-31 | University Of Virginia | Combined antiviral and antimediator treatment of common colds |
US5854269A (en) * | 1993-11-19 | 1998-12-29 | Schering-Plough Healthcare Products, Inc. | Nasal spray compositions |
KR100568436B1 (en) | 1996-02-27 | 2007-04-25 | 데이진 가부시키가이샤 | Powdery composition for nasal administration |
US5785988A (en) | 1996-05-10 | 1998-07-28 | Fust; Charles A. | Composition for freshening nostrils and sinus cavities |
US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
US6245735B1 (en) * | 1996-07-29 | 2001-06-12 | The Brigham And Women's Hospital, Inc. | Methods and products for treating pseudomonas infection |
US5908619A (en) | 1997-01-09 | 1999-06-01 | Minnesota Mining And Manufacturing Company | Hydroalcoholic compositions thickened using surfactant/polymer complexes |
GB2328443B (en) | 1997-08-21 | 2001-09-05 | Reckitt & Colmann Prod Ltd | In situ formation of pharmaceutically acceptable polymeric material |
EP0903151A1 (en) | 1997-09-22 | 1999-03-24 | ASTA Medica Aktiengesellschaft | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
US20010053775A1 (en) | 1998-01-30 | 2001-12-20 | Matthias Seidel | Nasal solutions |
US5988870A (en) | 1998-03-02 | 1999-11-23 | Partsky; Howard | Apparatus and method for diluting nasal sprays containing addictive compounds |
US5948414A (en) | 1998-03-24 | 1999-09-07 | Nouveau Technologies, Inc. | Herbal based nasal spray |
US6090403A (en) * | 1998-08-17 | 2000-07-18 | Lectec Corporation | Inhalation therapy decongestant with foraminous carrier |
US20020006961A1 (en) | 1999-05-14 | 2002-01-17 | Katz Stanley E. | Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
US6235312B1 (en) | 1999-05-14 | 2001-05-22 | Eastman Chemical Company | Liquid crystalline phase drug delivery vehicle |
US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US6565832B1 (en) * | 2000-01-31 | 2003-05-20 | Schering-Plough Healthcare Products, Inc. | Spray composition with reduced dripping |
US6576267B2 (en) | 2000-02-23 | 2003-06-10 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US6759062B2 (en) | 2000-02-23 | 2004-07-06 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
US20020022052A1 (en) | 2000-04-06 | 2002-02-21 | Dransfield Charles William | Transdermal delivery system |
US6644305B2 (en) * | 2000-04-14 | 2003-11-11 | Trudell Medical International | Nasal inhaler |
US7029694B2 (en) * | 2000-04-26 | 2006-04-18 | Watson Laboratories, Inc. | Compositions and methods for transdermal oxybutynin therapy |
US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
CN100489094C (en) * | 2001-03-23 | 2009-05-20 | 金克克国际有限公司 | Proteins with altered immunogenicity and methods of making and using the same |
US20040197270A1 (en) * | 2003-04-01 | 2004-10-07 | Mundschenk David D. | Topical formulations and delivery systems |
-
2003
- 2003-09-15 AU AU2003272517A patent/AU2003272517A1/en not_active Abandoned
- 2003-09-15 WO PCT/US2003/029329 patent/WO2004024187A2/en not_active Application Discontinuation
- 2003-09-15 US US10/663,010 patent/US7714011B2/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2115848A (en) * | 1934-12-29 | 1938-05-03 | Stanco Inc | Ephedrine composition |
US4724231A (en) * | 1985-04-16 | 1988-02-09 | Nastech Pharmaceutical, Inc. | Nasel compositions containing vitamin B12 |
EP0275054A1 (en) * | 1987-01-14 | 1988-07-20 | Toko Yakuhin Kogyo Kabushiki Kaisha | Ointment base and ointment |
EP0391342A1 (en) * | 1989-04-05 | 1990-10-10 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
WO1994000108A1 (en) * | 1992-06-19 | 1994-01-06 | The Procter & Gamble Company | Topical aromatic releasing compositions |
WO1994005330A1 (en) * | 1992-09-05 | 1994-03-17 | The Procter & Gamble Company | Nasal spray products |
US5760085A (en) * | 1993-04-30 | 1998-06-02 | The Procter & Gamble Company | Topical aromatic releasing compositions |
US6316483B1 (en) * | 1994-02-03 | 2001-11-13 | Schering Corporation | Oxymetazoline HCI and/or chlorpheniramine maleate nasal spray compositions |
WO1999038492A1 (en) * | 1998-01-30 | 1999-08-05 | Novartis Consumer Health S.A. | Nasal solutions |
WO2000010530A1 (en) * | 1998-08-24 | 2000-03-02 | The Procter & Gamble Company | Oral liquid mucoadhesive compositions |
US6080783A (en) * | 1998-09-01 | 2000-06-27 | Gum Tech International, Inc. | Method and composition for delivering zinc to the nasal membrane |
WO2000078297A2 (en) * | 1999-06-22 | 2000-12-28 | Boehringer Ingelheim International Gmbh | Stable xylometazoline and oxymetazoline solution |
Also Published As
Publication number | Publication date |
---|---|
US7714011B2 (en) | 2010-05-11 |
AU2003272517A1 (en) | 2004-04-30 |
US20040166066A1 (en) | 2004-08-26 |
AU2003272517A8 (en) | 2004-04-30 |
WO2004024187A2 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004024187A3 (en) | Compositions to reduce congestion and methods for application thereof to the nasal membrane | |
HUP0302881A2 (en) | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid | |
WO2004050021A3 (en) | Methods and compositions for applying pharmacologic agents to the ear | |
HK1066449A1 (en) | Liquid formulations for dermal application in treatment of parasitic insects in animals | |
WO2000018388A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
MY129406A (en) | Taste masked liquid pharmaceutical compositions | |
CA2308513A1 (en) | Method and composition for delivering zinc to the nasal membrane | |
HK1083009A1 (en) | Topical drug delivery using phosphatidylcholine | |
AU2002343191A1 (en) | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | |
MXPA02012407A (en) | Sprayable wound care compositions. | |
AU2003229084A1 (en) | Methods and formulations for the delivery of pharmacologically active agents | |
WO2000018386A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
WO2004021968A3 (en) | Solution for ungual application | |
WO2004100889A3 (en) | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin | |
WO2006053222A3 (en) | Instant patch for dermal drug delivery | |
HK1061975A1 (en) | Novel method and compostions for local treatment of meniere's disease, tinnitus and/or hearing loss | |
WO2005027815A8 (en) | Method of applying oral compositions | |
EP2292239A3 (en) | Remedies for diseases to be applied to eye | |
WO2004052345A8 (en) | Coating composition for taste masking coating and methods for their application and use | |
WO2000018387A3 (en) | Antibiotic compositions for treatment of the eye, ear and nose | |
AU1261501A (en) | Compositions and methods for intranasal delivery of active agents to the brain | |
AU2002215982A1 (en) | Topical treatment of mastalgia with arometese inhibitors such as androstendione | |
PT1651274E (en) | Bioadhesive gel based on hydroxyethylcellulose | |
WO2003082193A3 (en) | Suramin and derivatives thereof as topical microbicide and contraceptive | |
WO2004058282A3 (en) | Method of obtaining a soothing active ingredient, active ingredient and compositions obtained |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |